Quantification of eNOS mRNA in the canine cardiac vasculature by competitive PCR

被引:12
作者
Fulton, D
Papapetropoulos, A
Zhang, XP
Catravas, JD
Hintze, TH
Sessa, WC
机构
[1] Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pharmacol, New Haven, CT 06536 USA
[2] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA
[3] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA
[4] Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2000年 / 278卷 / 02期
关键词
nitric oxide; nitric oxide synthase; microvessels; complimentary deoxyribonucleic acid; endothelium;
D O I
10.1152/ajpheart.2000.278.2.H658
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The goal of the present study was to develop a competitive PCR assay to measure changes in the expression of endothelial nitric oxide synthase (eNOS) mRNA levels throughout the canine vascular tree. A partial sequence of canine eNOS cDNA (1.86 kb), inducible NOS (1.95 kb), and neuronal NOS (1.16 kb) was cultured from canine aortic endothelial cells, LPS-treated canine splenic vein endothelial cells, and from canine left ventricle, respectively. Competitor eNOS cDNA (eNOS-C) was constructed via recombinant PCR. Thus, with the use of a standard curve competitive PCR with eNOS-C, the amount of eNOS mRNA in 500 ng of total RNA was greatest in the circumflex > right coronary artery > left anterior descending coronary artery > aorta. The isolation of coronary microvessels from the left ventricle was associated with an enrichment of endothelial cell markers such as eNOS, von Willebrand factor, and caveolin-1, an observation supported by the detection of up to 15-fold higher levels of eNOS mRNA in coronary microvessels relative to the larger arteries. The ability to quantify changes in eNOS mRNA. levels throughout the canine vasculature should provide greater insight into the molecular mechanisms of how this gene is regulated in physiological and pathophysiological states.
引用
收藏
页码:H658 / H665
页数:8
相关论文
共 31 条
  • [1] Andries LJ, 1998, CIRC RES, V82, P195
  • [2] Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension
    Cardillo, C
    Kilcoyne, CM
    Quyyumi, AA
    Cannon, RO
    Panza, JA
    [J]. CIRCULATION, 1998, 97 (09) : 851 - 856
  • [3] IMPAIRED NEUROGENIC AND ENDOTHELIUM-MEDIATED RELAXATION OF PENILE SMOOTH-MUSCLE FROM DIABETIC MEN WITH IMPOTENCE
    DETEJADA, IS
    GOLDSTEIN, I
    AZADZOI, K
    KRANE, RJ
    COHEN, RA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (16) : 1025 - 1030
  • [4] Drexler H., 1994, Arzneimittel-Forschung, V44, P455
  • [5] The endothelial nitric-oxide synthase-caveolin regulatory cycle
    Feron, O
    Saldana, F
    Michel, JB
    Michel, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (06) : 3125 - 3128
  • [6] Dynamic activation of endothelial nitric oxide synthase by Hsp90
    García-Cardeña, G
    Fan, R
    Shah, V
    Sorrentino, R
    Cirino, G
    Papapetropoulos, A
    Sessa, WC
    [J]. NATURE, 1998, 392 (6678) : 821 - 824
  • [7] Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1
    GarciaCardena, G
    Fan, R
    Stern, DF
    Liu, JW
    Sessa, WC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (44) : 27237 - 27240
  • [8] Dissecting the interaction between nitric oxide synthase (NOS) and caveolin - Functional significance of the NOS caveolin binding domain in vivo
    GarciaCardena, G
    Martasek, P
    Masters, BSS
    Skidd, PM
    Couet, J
    Li, SW
    Lisanti, MP
    Sessa, WC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (41) : 25437 - 25440
  • [9] CONTROL OF REGIONAL BLOOD-FLOW BY ENDOTHELIUM-DERIVED NITRIC-OXIDE
    GARDINER, SM
    COMPTON, AM
    BENNETT, T
    PALMER, RMJ
    MONCADA, S
    [J]. HYPERTENSION, 1990, 15 (05) : 486 - 492
  • [10] GARLAND CJ, 1995, TRENDS PHARMACOL SCI, V16, P177